Is Sage Cognitive Performance Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Sage Cognitive Performance Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - These structural and functional changes in muscle fibers associated with sarcopenia decrease the quality of life of this population due to increased probability of falls, fractures, low physical performance, and neurological disorders [,]. [Garrido-Dzib Angel Gabriel (2026); evidence level 1] - In this continuum, mild neurocognitive disorder, or mild cognitive impairment (MCI), corresponds to an intermediate clinical state in which there is objective evidence of moderate cognitive decline (e.g., in memory, learning, or language), without substantial impairment of functional or social autonomy. [Garrido-Dzib Angel Gabriel (2026); evidence level 1] - Age is the main risk factor for MCI, although it is important to note that this condition may also manifest at earlier stages of life (from approximately 50 years onwards) []. [Garrido-Dzib Angel Gabriel (2026); evidence level 1] - 1 2 Latin America (LATAM) is a region comprising the countries and territories of Mexico, Central America, South America, and some Caribbean countries. [Garrido-Dzib Angel Gabriel (2026); evidence level 1] - Risk of bias and reporting quality were assessed with PROBAST (Prediction Model Risk of Bias Assessment Tool) and TRIPOD (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis); implementation readiness was assessed with the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework and a Technology Readiness Level (TRL)-style rubric. [Kim S (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.